Ensuring adequate protein intake is critical
The SURMOUNT-1 trial (tirzepatide, published in NEJM 2022) demonstrated that participants with obesity or overweight without diabetes who received tirzepatide experienced weight reductions of 16.0% (5mg), 21.4% (10mg), and 22.5% (15mg) over 72 weeks
Even with this unprecedented incretin power, the extratumoral microenvironment, hyperinsulinemia-driven FAK/PYK2 activation and collagen remodeling in adipose, kidney, liver, and heart, remains untouched and continues to fuel residual progression in 5070 % of obesity, T2D, CKD & HFpEF patients
What You Actually Get in the Box When your first Trava shipment arrives, the box should contain a few specific things
As we age, our natural production of collagen begins to decline
N-acetylcysteine amide (naca) prevents retinal degeneration by up-regulating reduced glutathione production and reversing lipid peroxidation